An observational comparative study of clinical efficacy and safety of chlordiazepoxide and lorazepam in alcohol withdrawal syndrome
Abstract
Background: Currently, Benzodiazepines like chlordiazepoxide, diazepam and lorazepam are the preferred drugs in the management of Alcohol withdrawal syndrome (AWS). These drugs of similar class are different in their pharmacokinetic profile which differently affect in AWS. Chlordiazepoxide is longer acting and converted to active metabolites in the liver, while lorazepam is shorter acting, with no active metabolites.
Materials and methods: An observational, prospective and comparative study conducted in 100 patients of AWS. They received either Chlordiazepoxide or Lorazepam and divided into two comparison groups at the screening. Observation was started from day of admission to every day till day of discharge. The initial withdrawal assessment and subsequent changes in withdrawal during treatment were assessed using the Clinical Institute Withdrawal Assessment for Alcohol scale, revised (CIWA-Ar) in both the groups. Clinical global impression (CGI) score was also used to evaluate drug efficacy in both the groups. Details of adverse drug reactions, if any appear were recorded.
Results: CIWA-Ar score, CGI-Severity (CGI-S) score and CGI-Improvement (CGI-I) score showed statistically significant difference between two groups. But percentage reduction in CIWA-Ar, CGI-S and CGI-I score were almost similar in both groups. Intra group comparison at different duration of treatment progressed and in between days of treatment there was statistically significant reduction of these scores. Considering no. of adverse events, reported adverse events causality, severity, predictability and preventability assessment, both drugs were safe.
Conclusion: Both the drugs had almost similar efficacy in terms of to reduce CIWA-Ar score, CGI-S score, CGI-I score and similar safety profile.
Downloads
References
2. World Health Organization. Global status report on alcohol and health, 2014. [Online] 2014. [cited 2015 Sep 24]; Available from: URL:www.who.int/substance.../global_alcohol_report/msb_gsr_2014_3.pdf
3. Alcohol use disorder. National Health Portal. [Online]; Available from: URL:http://www.nhp.gov.in/healthlyliving/alcohol-use-disorder
4. Alcohol withdrawal. WebMD. [Online] 2015. [cited 2015 Sep 24]; Available from: URL: www.webmd.com/mental.../alcohol-withdrawal-symptoms-treatments
5. Bayard M, Mclntyre J, Hill KR, Woodside J Jr. Alcohol withdrawal syndrome. Am Fam Physician. 2015; 69(6):1443-50. Available from: URL: http://www.aafp.org/afp/2004/0315/p1443.html
6. Ramanujam R, L P, G S, Thimmaiah RS. A comparative study of the clinical efficacy and safety of Lorazepam and chlordiazepoxide in alcohol dependence syndrome. J Clin Diagn Res. 2015 Mar;9(3):FC10-3. doi: 10.7860/JCDR/2015/11887.5678. Epub 2015 Mar 1. [PubMed]
7. Kumar CN, Andrade C, Murthy P. A randomized, double-blind comparison of lorazepam and chlordiazepoxide in patients with uncomplicated alcohol withdrawal. J Stud Alcohol Drugs. 2009 May;70(3):467-74.
8. Miller WC Jr, McCurdy L. A double-blind comparison of the efficacy and safety of lorazepam and diazepam in the treatment of the acute alcohol withdrawal syndrome. Clin Ther. 1984;6(3):364-71. [PubMed]
9. Rajmohan V, Sushil K, Mohandas E. A double blind randomised comparison of chlordiazepoxide and lorazepam in alcohol withdrawal. Asian J Psychiatr. 2013 Oct;6(5):401-3. doi: 10.1016/j.ajp.2013.05.003. Epub 2013 Jun 13. [PubMed]
10. Haber P, Lintzeris N, Proude E, Lopatko O. Guidelines for the treatment of alcohol problems. [Online]. 2009 [cited 2015 Sep 26]; Available from: URL: http://www.drugsandalcohol.ie/20201/1/Gudelines_for_treatment_of_alcohol_problems.pdf
11. Department of Surgical education, Orlando regional medical center guideline for Alcohol withdrawal. [Online]. 2009 [cited 2015 Sep 27]; Available from: URL:http://www.surgicalcriticalcare.net/Guidelines/Alcohol%20withdrawal%202015.pdf
12. Chourishi A, Raichandani O, Chandraker S, Chourishi S. A comparative study of efficacy & tolerability of lorazepam and gabapentin in the treatment of alcohol withdrawal syndrome. Int J Pharm Sci Rev Res. 2010; 3(2):80-84. Available from: URL: http://www.globalresearchonline.net/journalcontents/Volume3issue2/Article%20014.pdf
13. Kattimani S, Bharadwaj B. Clinical management of alcohol withdrawal: A systematic review. Ind Psychiatry J. 2013 Jul;22(2):100-8. doi: 10.4103/0972-6748.132914. [PubMed]
14. McKeon A Frye MA, Delanty N. The alcohol withdrawal syndrome. J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):854-62. Epub 2007 Nov 6. [PubMed]
15. Nyblom H, Berggren U, Balldin J, Olsson R. High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. Alcohol & Alcoholism. 2004; 39(4): 336–339. [PubMed]
16. Maldonado JR. An approach to the patient with substance use and abuse. Med Clin North Am. 2010 Nov;94(6):1169-205, x-i. doi: 10.1016/j.mcna.2010.08.010. [PubMed]
17. Busner J, Targum SD. The Clinical Global Impressions Scale: Applying a research tool in clinical practice. Psychiatry (Edgmont). 2007; 4(7): 28-37.
18. Solomon J, Rouck LA, Koepke HH. Double-blind comparison of lorazepam and chlordiazepoxide in the treatment of the acute alcohol abstinence syndrome. Clin Ther. 1983;6(1):52-8. [PubMed]
19. Clinical Institute Withdrawal Assessment of Alcohol Scale, Revised. Pdf [Online]; Available from: URL: https://umem.org/files/uploads/1104212257_CIWA-Ar.pdf
20. Clinical Global Impression (CGI) Scale. pdf [Online]; Available from: URL: http://www.psywellness.com.sg/docs/CGI.pdf
OAI - Open Archives Initiative
